This inventor holds 19 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Port Systems, L.l.c., University of Michigan, Tsrl, Inc.. Active years: 1987-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 8 
3 out of 3,525 
2 out of 7 
Years Active: 1987-2015
Title: Gordon L Amidon: Pioneering Innovations in Pharmaceutical Delivery Systems
Introduction
Gordon L Amidon, based in Ann Arbor, MI, is a distinguished inventor holding 19 patents in the field of pharmaceutical innovation. His work has significantly contributed to advancements in drug delivery systems and prodrug development, exemplifying the intersection of chemistry and medical science.
Latest Patents
Among his latest contributions to the industry are innovative prodrugs of neuraminidase inhibitors. This new class of prodrugs is characterized by a modified carboxyl group that transforms into carbonyl ethoxy amino acids, dipeptides, or tripeptides. The modifications include alterations to guanidine groups and primary alcohols, leading to increased oral bioavailability of therapeutic agents like zanamivir, oseltamivir, and peramivir. These prodrugs are essential in effectively inhibiting viral infections during the viral reproductive cycle.
Another notable patent involves a device for the controlled release of pharmaceutical agents. This device includes a covered container with an aperture and an aperture cover, allowing for the precise delivery of pharmaceutical agents in conjunction with excipient formulations, thereby enhancing therapeutic effectiveness.
Career Highlights
Gordon Amidon has built a prolific career, working with multiple institutions and companies that are at the forefront of pharmaceutical research. Notably, he has collaborated with Port Systems, L.L.C. and the University of Michigan, playing vital roles in advancing drug delivery technologies that have broad applications in healthcare.
Collaborations
Throughout his career, Amidon has partnered with esteemed professionals, including John R Crison and Glen D Leesman, fostering an environment of innovation and collaboration. These partnerships have been instrumental in developing pioneering drug delivery systems and research initiatives that push the boundaries of existing knowledge in the field.
Conclusion
Gordon L Amidon’s impactful contributions to pharmaceuticals through his innovative patents and collaborations illustrate his commitment to enhancing drug delivery methods. His work continues to inspire future advancements in the field, establishing him as a key figure in the evolution of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile